查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1528111

有源植入式医疗设备的全球市场

Active Implantable Medical Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球有源植入医疗设备市场将达到 513 亿美元

有源植入式医疗设备的全球市场预计 2023 年为 305 亿美元，预计到 2030 年将达到 513 亿美元，2023 年至 2030 年复合年增长率为 7.7%。植入式心臟整流去颤器是本报告分析的细分市场之一，预计复合年增长率为 7.9%，到分析期结束时将达到 172 亿美元。在分析期间，植入式心臟心律调节器市场的复合年增长率预计为 8.6%。

美国市场预估成长84亿美元，中国复合年增率为7.3%

2023年美国主动植入式医疗设备市场规模预估为84亿美元。中国作为世界第二大经济体，预计2030年市场规模将达79亿美元，2023-2030年分析期间复合年增长率为7.3%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 7.2% 和 6.2%。在欧洲，德国的复合年增长率预计约为 6.2%。

全球主动植入式医疗设备市场 - 主要趋势与驱动因素总结

为什么有源植入式医疗设备会彻底改变医疗保健？

主动式植入式医疗设备(AIMD) 已成为医疗保健产业的游戏规则改变者，为管理慢性病和改善病患治疗效果提供了前所未有的解决方案。这些设备包括心律调节器、心臟去颤器、神经刺激设备和人工电子耳，旨在植入体内监测、诊断和治疗各种医疗状况。 AIMD 中先进技术的整合显着增强了其功能，可实现持续监控并向医疗保健提供者即时传输资料。这种能力不仅可以及时进行医疗干预，还可以减少再入院和医疗费用。 AIMD 的发展代表了个人化医疗的重大飞跃，可根据每位患者的特定需求提供量身定制的治疗方法。

技术进步将如何提高 AIMD 的有效性？

技术进步对 AIMD 的发展和有效性发挥着至关重要的作用。随着微电子、无线通讯和节能电源的引入，AIMD 变得更小、更可靠、更耐用。生物相容性材料的创新提高了植入的安全性和耐用性，降低了副作用和设备故障的风险。此外，人工智慧和机器学习演算法的整合使 AIMD 能够适应患者生理状态的变化并优化治疗结果。这些技术进步不仅提高了AIMD的性能，还扩大了其应用范围，使其能够解决更广泛的疾病状态。因此，患者可以受益于更有效、侵入性更小的治疗方法，从而提高生活品质并延长存活率。

哪些趋势和市场动态会影响 AIMD？

AIMD 市场受到多种新兴趋势和市场动态的影响。世界人口老化是推动 AIMD 需求的关键因素，因为心血管疾病、神经系统疾病和听力损失等慢性疾病的盛行率随着老龄化的增长而增加。此外，糖尿病和肥胖症等与文明病的增加进一步增加了对先进医疗干预措施的需求。法律规范和核准流程也变得更加严格，以确保 AIMD 的安全性和有效性。此外，远端医疗和远端监控技术的进步补充了 AIMD 的能力，并实现患者和医疗保健提供者之间的无缝连接。这些趋势支撑了 AIMD 在应对现代社会复杂的医疗保健挑战方面日益增长的重要性。

有源植入医疗设备市场成长的驱动力是什么？

有源植入式医疗设备市场的成长受到多种因素的推动。关键因素之一是持续的技术创新，提高目前植入式医疗设备的功能和可靠性。慢性病的增加和人口老化对 AIMD 产生了巨大的需求。此外，医疗保健基础设施的扩张，尤其是在新兴市场，为 AIMD 製造商带来了巨大的成长机会。在医疗设备製造商成功的临床结果和广泛的营销努力的推动下，患者对 AIMD 的认识和接受度也在不断提高。监管支持和有利的报销政策正在进一步加速市场采用。此外，微创手术的趋势以及 AIMD 与远端监控和管理数位健康平台的整合正在推动市场向前发展。总的来说，这些因素促进了主动植入医疗设备市场的强劲成长和动态发展，使其成为现代医疗保健服务的重要组成部分。

调查企业举例（共13家）

  • Abbott Laboratories
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cochlear Ltd.
  • LivaNova PLC
  • MED-EL Elektromedizinische Gerate Gesellschaft mbH
  • Medtronic PLC
  • Nurotron Biotechnology Co., Ltd.
  • Sonova AG
  • William Demant Holding A/S

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 世界其他地区

第四章 比赛

简介目录
Product Code: MCP10058

Global Active Implantable Medical Devices Market to Reach US$51.3 Billion by 2030

The global market for Active Implantable Medical Devices estimated at US$30.5 Billion in the year 2023, is expected to reach US$51.3 Billion by 2030, growing at a CAGR of 7.7% over the analysis period 2023-2030. Implantable Cardioverter Defibrillators, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$17.2 Billion by the end of the analysis period. Growth in the Implantable Cardiac Pacemakers segment is estimated at 8.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$8.4 Billion While China is Forecast to Grow at 7.3% CAGR

The Active Implantable Medical Devices market in the U.S. is estimated at US$8.4 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$7.9 Billion by the year 2030 trailing a CAGR of 7.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.2% and 6.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.2% CAGR.

Global Active Implantable Medical Devices Market - Key Trends and Drivers Summarized

Why Are Active Implantable Medical Devices Revolutionizing Healthcare?

Active implantable medical devices (AIMDs) have emerged as a game-changer in the healthcare industry, offering unprecedented solutions for managing chronic diseases and improving patient outcomes. These devices, which include pacemakers, defibrillators, neurostimulators, and cochlear implants, are designed to be implanted into the body to monitor, diagnose, and treat various medical conditions. The integration of advanced technologies in AIMDs has significantly enhanced their functionality, enabling continuous monitoring and real-time data transmission to healthcare providers. This capability not only allows for timely medical interventions but also reduces hospital readmissions and healthcare costs. The evolution of AIMDs represents a significant leap forward in personalized medicine, providing tailored treatments that cater to the specific needs of individual patients.

How Do Technological Advancements Boost AIMDs' Effectiveness?

Technological advancements have played a pivotal role in the development and effectiveness of AIMDs. The incorporation of microelectronics, wireless communication, and energy-efficient power sources has made these devices smaller, more reliable, and longer-lasting. Innovations in biocompatible materials have improved the safety and durability of implants, reducing the risk of adverse reactions and device failure. Moreover, the integration of artificial intelligence and machine learning algorithms enables AIMDs to adapt to the changing physiological conditions of patients, optimizing therapeutic outcomes. These technological strides not only enhance the performance of AIMDs but also expand their applications, making them suitable for a wider range of medical conditions. As a result, patients benefit from more effective and less invasive treatment options, leading to better quality of life and prolonged survival rates.

What Trends and Market Dynamics Are Influencing AIMDs?

The AIMD market is influenced by several emerging trends and market dynamics. The aging global population is a significant factor driving the demand for AIMDs, as the prevalence of chronic diseases such as cardiovascular disorders, neurological conditions, and hearing impairments increases with age. Additionally, the rise in lifestyle-related diseases, such as diabetes and obesity, has further escalated the need for advanced medical interventions. Regulatory frameworks and approval processes are becoming more stringent, ensuring the safety and efficacy of AIMDs, which in turn boosts patient confidence and adoption rates. Furthermore, advancements in telemedicine and remote monitoring technologies are complementing the functionality of AIMDs, enabling seamless connectivity between patients and healthcare providers. These trends underscore the growing importance of AIMDs in addressing the complex healthcare challenges of the modern world.

What Drives the Growth in the Active Implantable Medical Devices Market?

The growth in the active implantable medical devices market is driven by several factors. One of the primary drivers is the continuous technological innovation that enhances the capabilities and reliability of these devices. The increasing prevalence of chronic diseases and the growing aging population create a substantial demand for AIMDs. Moreover, the expanding healthcare infrastructure, particularly in emerging markets, provides significant growth opportunities for AIMD manufacturers. Patient awareness and acceptance of these devices are also on the rise, driven by successful clinical outcomes and extensive marketing efforts by medical device companies. Regulatory support and favorable reimbursement policies further accelerate market adoption. Additionally, the trend towards minimally invasive surgical procedures and the integration of AIMDs with digital health platforms for remote monitoring and management propel the market forward. These factors collectively contribute to the robust growth and dynamic evolution of the active implantable medical devices market, making it a critical component of modern healthcare delivery.

Select Competitors (Total 13 Featured) -

  • Abbott Laboratories
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cochlear Ltd.
  • LivaNova PLC
  • MED-EL Elektromedizinische Gerate Gesellschaft m.b.H.
  • Medtronic PLC
  • Nurotron Biotechnology Co., Ltd.
  • Sonova AG
  • William Demant Holding A/S

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Active Implantable Medical Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Chronic Diseases Spurs Demand for AIMDs
    • Aging Population Expands Addressable Market Opportunity for AIMDs
    • Technological Innovations Propel Growth in Active Implantable Medical Devices
    • Advances in Microelectronics Strengthen Business Case for AIMDs
    • Integration of AI and Machine Learning Accelerates Demand for Intelligent Implants
    • Enhanced Biocompatible Materials Drive Adoption of Safer AIMDs
    • Telemedicine and Remote Monitoring Technologies Propel Market Growth
    • Minimally Invasive Procedures Sustain Growth in AIMD Adoption
    • Expanding Healthcare Infrastructure in Emerging Markets Expands Market Opportunities
    • Innovations in Power Sources and Energy Efficiency Propel AIMD Advancements
    • Digital Health Integration Drives Demand for Connected AIMDs
    • Data Security and Privacy Concerns Create Challenges and Opportunities for AIMDs
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Active Implantable Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Active Implantable Medical Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Implantable Cardioverter Defibrillators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Implantable Cardioverter Defibrillators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Implantable Cardiac Pacemakers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Implantable Cardiac Pacemakers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Implantable Cardiac Pacemakers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Ventricular Assist Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Ventricular Assist Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Ventricular Assist Device by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Implantable Hearing Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Implantable Hearing Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Implantable Hearing Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Active Implantable Medical Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Implantable Heart Monitors / Insertable Loop Recorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Implantable Heart Monitors / Insertable Loop Recorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Implantable Heart Monitors / Insertable Loop Recorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Neurostimulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Neurostimulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Neurostimulators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Active Implantable Medical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2014, 2024 & 2030
  • JAPAN
    • Active Implantable Medical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 29: Japan Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Japan Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Japan 16-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2014, 2024 & 2030
  • CHINA
    • Active Implantable Medical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 32: China Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: China Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: China 16-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2014, 2024 & 2030
  • EUROPE
    • Active Implantable Medical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 35: Europe Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 36: Europe Historic Review for Active Implantable Medical Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Europe 16-Year Perspective for Active Implantable Medical Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 38: Europe Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Europe Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Europe 16-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2014, 2024 & 2030
  • FRANCE
    • Active Implantable Medical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 41: France Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: France Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: France 16-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2014, 2024 & 2030
  • GERMANY
    • Active Implantable Medical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 44: Germany Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Germany Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Germany 16-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 47: Italy Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Italy Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Italy 16-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Active Implantable Medical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 50: UK Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: UK Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: UK 16-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 53: Rest of Europe Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Rest of Europe Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Rest of Europe 16-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Active Implantable Medical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Asia-Pacific 16-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 59: Rest of World Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Rest of World Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Rest of World 16-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2014, 2024 & 2030

IV. COMPETITION